Exencial Wealth Advisors, LLC Eli Lilly & CO Transaction History

Exencial Wealth Advisors, LLC

$2.72 Billion
Q3 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 6,791 shares of LLY stock, worth $5.21 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

6,791

Previous 6,861 1.02%

Holding current value

$5.21 Million

Previous $6.21 Million 3.14%

% of portfolio

0.22%

Previous 0.24%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $54,049 - $67,201	-70 Reduced 1.02%	6,791 $6.02 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $256,603 - $321,800	-354 Reduced 4.91%	6,861 $6.21 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $141,535 - $189,354	-239 Reduced 3.21%	7,215 $5.61 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $150,204 - $177,071	286 Added 3.99%	7,454 $4.35 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $285,163 - $393,140	-656 Reduced 8.38%	7,168 $3.85 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $13,328 - $17,821	38 Added 0.49%	7,824 $3.67 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $167,429 - $196,637	-539 Reduced 6.47%	7,786 $2.67 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.14 Million - $1.33 Million	3,557 Added 74.6%	8,325 $3.05 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $5,336 - $6,081	-18 Reduced 0.38%	4,768 $1.54 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $170,304 - $199,961	611 Added 14.63%	4,786 $1.55 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $299,229 - $371,866	1,275 Added 43.97%	4,175 $1.2 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $56,437 - $70,039	251 Added 9.48%	2,900 $801,000
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $2.05 Million - $2.53 Million	-9,271 Reduced 77.78%	2,649 $612,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1.79 Million - $2.32 Million	9,916 Added 494.81%	11,920 $2.74 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $1.66 Million - $2.15 Million	-10,094 Reduced 83.44%	2,004 $374,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $1.61 Million - $2.13 Million	-12,350 Reduced 50.52%	12,098 $2.04 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $3.37 Million - $3.9 Million	23,044 Added 1641.31%	24,448 $3.62 Million
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $191,533 - $230,508	1,404 New	1,404 $231,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Account

Exencial Wealth Advisors, LLC Eli Lilly & CO Transaction History